Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dómine

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1992
Growth and differentiation controlG E Francis, M Dómine
Revista Clinica Espanola|November 1, 1992
[Castleman's disease. A multifactorial study]G Echezarreta, M Santos, C Rivas, et al.
Journal of Cutaneous Pathology|December 31, 1998
Histopathology of cutaneous reaction to granulocyte colony-stimulating factor: another pseudomalignancyM C Fariña, L Requena, M Dómine, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 6, 2013
SEOM clinical guidelines for the treatment of small-cell lung cancer 2013M Dómine Gómez, T Morán Bueno, A Artal Cortés, et al.
Seminars in Oncology|August 18, 2001
Gemcitabine and carboplatin for patients with advanced non-small cell lung cancerM Dómine, V Casado, L G Estévez, et al.
British Journal of Haematology|December 1, 1992
Polyethylene glycol (PEG) modification of granulocyte-macrophage colony stimulating factor (GM-CSF) enhances neutrophil priming activity but not colony stimulating activityC Knüsli, C Delgado, F Malik, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 23, 2015
SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015R García-Campelo, R Bernabé, M Cobo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 11, 2020
SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019)M Dómine, T Moran, D Isla, et al.
Clinical Breast Cancer|May 15, 2003
Gemcitabine/vinorelbine in metastatic breast cancer patients previously treated with anthracyclines: results of a phase II trialF Lobo, J A Virizuela, F J Dorta, et al.
Cancer Epidemiology|March 14, 2015
Prevalence of EGFR mutations in newly diagnosed locally advanced or metastatic non-small cell lung cancer Spanish patients and its association with histological subtypes and clinical features: The Spanish REASON studyE Esteban, M Majem, M Martinez Aguillo, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1992
Growth and differentiation controlG E Francis, M Dómine
Revista Clinica Espanola|November 1, 1992
[Castleman's disease. A multifactorial study]G Echezarreta, M Santos, C Rivas, et al.
Journal of Cutaneous Pathology|December 31, 1998
Histopathology of cutaneous reaction to granulocyte colony-stimulating factor: another pseudomalignancyM C Fariña, L Requena, M Dómine, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 6, 2013
SEOM clinical guidelines for the treatment of small-cell lung cancer 2013M Dómine Gómez, T Morán Bueno, A Artal Cortés, et al.
Seminars in Oncology|August 18, 2001
Gemcitabine and carboplatin for patients with advanced non-small cell lung cancerM Dómine, V Casado, L G Estévez, et al.
British Journal of Haematology|December 1, 1992
Polyethylene glycol (PEG) modification of granulocyte-macrophage colony stimulating factor (GM-CSF) enhances neutrophil priming activity but not colony stimulating activityC Knüsli, C Delgado, F Malik, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 23, 2015
SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015R García-Campelo, R Bernabé, M Cobo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 11, 2020
SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019)M Dómine, T Moran, D Isla, et al.
Clinical Breast Cancer|May 15, 2003
Gemcitabine/vinorelbine in metastatic breast cancer patients previously treated with anthracyclines: results of a phase II trialF Lobo, J A Virizuela, F J Dorta, et al.
Cancer Epidemiology|March 14, 2015
Prevalence of EGFR mutations in newly diagnosed locally advanced or metastatic non-small cell lung cancer Spanish patients and its association with histological subtypes and clinical features: The Spanish REASON studyE Esteban, M Majem, M Martinez Aguillo, et al.
Pageof 3